Clin Nephrol. 2023 Jun;99(6):274-282. doi: 10.5414/CN111065.
HbA1c variability may be related to risk of poor prognoses in chronic kidney disease patients with type 2 diabetes mellitus (T2DM). The aim of this study was to investigate whether HbA1c variability is associated with rapid renal function decline and the related risk factors in type 2 diabetic nephropathy (DN).
An observational analysis was performed on 387 DN patients who were diagnosed by kidney biopsy from January 2006 through January 2016 at the Department of Nephrology, Jinling Hospital Affiliated to Nanjing University. The rapid decliners were defined as an estimated glomerular filtration rate (eGFR) decline slope ≥ 5 mL/min/1.73m/year. HbA1c variability and 24 baseline clinicopathologic parameters was evaluated using the least absolute shrinkage and selection operator regression (LASSO) and multivariate logistic regression. The nomogram method was applied to score the factors, and a scoring model was constructed.
HbA1c variability positively correlated with the rate of renal function decline (r = 0.277; p < 0.001). Higher baseline eGFR, lower serum calcium concentration, glomerular lesions, arteriosclerosis, and interstitial fibrosis and tubular atrophy (IFTA) were selected into the nomogram. The calibration curve for the probability of survival showed good agreement between the prediction by nomogram and actual observation. The C-index for predicting survival was 0.811 (95% confidence interval (CI) 0.680 - 0.785).
The proposed nomogram and score provide a useful risk estimate of fast renal function decline in patients with type 2 diabetic nephropathy.
糖化血红蛋白(HbA1c)变异性可能与 2 型糖尿病(T2DM)慢性肾脏病(CKD)患者预后不良的风险有关。本研究旨在探讨 HbA1c 变异性与 2 型糖尿病肾病(DN)患者肾功能快速下降及其相关危险因素的关系。
对 2006 年 1 月至 2016 年 1 月在南京大学附属金陵医院肾内科经肾活检诊断为 DN 的 387 例患者进行观察性分析。将估算肾小球滤过率(eGFR)下降斜率≥5 mL/min/1.73m/年的患者定义为快速下降者。采用最小绝对收缩与选择算子回归(LASSO)和多因素逻辑回归评估 HbA1c 变异性和 24 项基线临床病理参数。采用列线图法对各因素进行评分,并构建评分模型。
HbA1c 变异性与肾功能下降率呈正相关(r=0.277,p<0.001)。较高的基线 eGFR、较低的血清钙浓度、肾小球病变、动脉硬化和间质纤维化和肾小管萎缩(IFTA)被选入列线图。生存概率的校准曲线显示,列线图预测与实际观察结果之间具有良好的一致性。预测生存的 C 指数为 0.811(95%置信区间(CI)0.680~0.785)。
本研究提出的列线图和评分可用于评估 2 型糖尿病肾病患者肾功能快速下降的风险。